As Delhi’s AQI hits a new high, it is essential to know the effect it can have on our skin. Know the preventive measures from ...

Top-line results show that 64.7% of patients achieved clear or almost clear skin measured using the Investigator's Global ...

The companies’ icotrokinra, or JNJ-2113, significantly cleared skin compared to placebo in patients with moderate to severe ...

Johnson & Johnson (J&J) has reported positive topline outcomes from its Phase III ICONIC-LEAD trial of oral icotrokinra ...

The following is a summary of “Identification of risk factors associated with metabolic dysfunction-associated steatotic liver disease in psoriatic patients,” published in the November 2024 issue of ...

Vista, CA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Mindera Health, a leader in precision medicine for dermatological conditions, today announced a strategic partnership with the National Psoriasis ...

Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...

The once-daily pill, icotrokinra, was tested in patients with moderate-to-severe plaque psoriasis, a skin condition that ...

Cannabinol modulates distinct endocannabinoid system elements and exerts anti-inflammatory effectsSupports therapeutic ...

PM ET Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from chronic skin ...

If you're dealing with chronic skin conditions, such as eczema or psoriasis, your skin is more vulnerable to environmental changes so you might also be more likely to get itchy skin during chilly ...

An experimental pill developed by Johnson & Johnson and Protagonist Therapeutics significantly cleared skin in most people ...